FDA launches pilot program that aims to speed the time to first-in-human drug trials

RegulatoryPositive

AI Analysis

Summary

The FDA has launched a pilot program designed to accelerate the timeline for initiating first-in-human drug trials. This regulatory initiative aims to streamline the drug development process.

Importance:5/10

Sentiment:

0.60

FDAregulatoryfirst-in-humanpilot programdrug development

Related Companies

$TRAX

Read the original article

Published by Seeking Alpha Healthcare on September 15, 2026 3:26 PM

Read Original